Get started
RocketTickers

Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alf

Long
Alkermes plc (NASDAQ:ALKS)  
RocketTickers  
NASDAQ:ALKS   Alkermes plc
Beyond Technical Analysis
0
1
beyondta
ALKS: Alkermes plc
2021-10-25 07:00:00
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.